[1]
Z. Khalid and A. Ali, “Assessment of Serum Podocalyxin as a Biomarker for Diabetic Nephropathy in Type 2 Diabetes patients in Duhok City”, JLBSR, vol. 3, no. 02, pp. 71 - 75, Nov. 2022.